Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33K Sell
122
-141
-54% -$1.5K ﹤0.01% 917
2026
Q1
$2.92K Buy
263
+37
+16% +$471 ﹤0.01% 843
2025
Q4
$3.71K Hold
226
﹤0.01% 817
2025
Q3
$3.02K Sell
226
-1,539
-87% -$18.2K ﹤0.01% 883
2025
Q2
$22.6K Buy
1,765
+1,133
+179% +$13.6K ﹤0.01% 411
2025
Q1
$6.51K Buy
632
+231
+58% +$2.97K ﹤0.01% 540
2024
Q4
$5.1K Buy
+401
New +$5.3K ﹤0.01% 385

Other funds holding PATH

Clearstead Trust's PATH Position: Q2 2026 in Review

Clearstead Trust reduced its UiPath (PATH) stake by 54% in Q2 2026, selling an estimated $1.5K and leaving 122 shares worth $1.33K. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Clearstead Trust first reported a position in PATH in Q4 2024 and has held it in 7 quarters since. The position peaked at $22.6K in Q2 2025. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Clearstead Trust held 122 shares of UiPath worth $1.33K as of Q2 2026.
  • Clearstead Trust sold 141 UiPath shares in Q2 2026, an estimated $1.5K.
  • UiPath made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #917 holding.
  • Clearstead Trust first reported a position in UiPath in Q4 2024 and has held it in 7 quarters since.
  • Clearstead Trust's UiPath position peaked at $22.6K in Q2 2025.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.